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As biotechnology develops, we could see the advent of biological pollution,
which could be more dangerous than nuclear or chemical pollution.1
Monsanto’s agricultural biotechnology provides improvements in quality and
yield of crops, and benefits the environment where crops are grown.2
Agricultural and environmental applications of modern biotechnology have
spurred considerable controversy about their environmental risks and potential
to alter the environmental impacts of other technologies and practices, such
as pesticide use. The range of biotechnology products under development is
expanding rapidly, and thus the potential for controversy over the environ-
mental effects of biotechnology products is also increasing.
The purpose of this paper is to examine environmental issues associated
with novel genetically engineered organisms being developed for agricultural,
pharmaceutical, and environmental applications. First, I will consider the pur-
poses of these novel biotechnology products and whether environmentalists
view these products as environmentally beneficial. Second, I will consider
the environmental risks of these novel biotechnology products. Third, I will
examine one novel regulatory approach to managing environmental impacts
of one category of biotechnology products.
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ARE NOVEL BIOTECHNOLOGY PRODUCTS GOOD FOR THE ENVIRONMENT?
Biotechnology products frequently are touted as environmentally beneficial.
Even in the face of such claims, however, it is unclear to many environmen-
talists whether biotechnology products will be good for the environment. In
part, this is simply because of the increasingly varied nature of biotechnology
products, which range from industrial chemicals to transgenic animals. It is
unreasonable to expect that as a class, biotechnology products will be “good”
or “bad” for the environment. But even individual biotechnology products or
types of biotechnology products face skepticism from the environmental
community, for at least two reasons.
The first reason is that the environmental community has grown wary of
environmental claims in general. As public support for environmental pro-
tection has grown, corporate environmental claims for products have become
more common. Unfortunately, these claims are not always legitimate. Plastic
supermarket bags, for example, sometimes are touted as “ecological,” even
though the bags are not made from recycled materials and customers frequently
dispose of the bags after one use. The practice of telling consumers that par-
ticular products are good for the environment, even when their environmental
benefits are dubious, has become so common that the environmental com-
munity has given this practice a special name: greenwashing. As greenwashing
has become common, so has legitimate skepticism of environmental claims —
including claims for biotechnology products.
Second, skepticism about environmental claims for novel biotechnology
products is also based on past experience with hype concerning the potential
of biotechnology. In the past, for example, biotechnology’s promoters have
promised that fertilizers will become unnecessary as crops are engineered to
fix their own nitrogen, and that pesticides will become obsolete as crops are
engineered to resist insects and other pests. Those unrealistic claims have
spurred general caution about environmental promises for biotechnology
products.
As a specific illustration of the environmental community’s response to
biotechnology products, consider bioremediation, a technology that has been
promoted heavily as one way in which biotechnology will aid environmental
protection. Most environmentalists support the concept of bioremediation —
harnessing natural processes to degrade hazardous chemicals. Nevertheless, the
environmental community has not rushed to embrace bioremediation as the
solution to problems with hazardous wastes.
In part, this response is based on the potential of environmental “snake oil”
to be disguised as a legitimate bioremediation product. Following the oil spill
from the tanker Mega Borg off the coast of Texas in 1990, for example, one
Texas company promoted heavily the success of its bioremediation product —
bacteria that supposedly “eat” oil on the surface of the ocean. According to a
report published by the Texas General Land Office, these bacteria largely
dissipated an oil slick from the Mega Borg in just seven hours, with portions of
the slick breaking up in just 30 minutes. The speed of this degradation is diffi-
cult to believe, especially given that the experimental design had no replication
of treatment and control areas, and because the oil in the treatment area simply
may have been dispersed by wind and water. The relatively low cost of such
bioremediation techniques makes them attractive to government agencies and
companies that must remediate waste, but also signals caution to many envi-
ronmentalists. Reliance on inexpensive but unproved bioremediation products
could cause considerable environmental harm if the result is that more effica-
cious cleanup methods are not used.
Not just skepticism, however, has caused bioremediation’s relatively low
profile in the environmental community. Many environmentalists are now
focused on pollution prevention rather than remediation of wastes. Changing
industrial processes to minimize the amount of waste produced is regarded as
the best way to end the problems caused by chemical wastes. Over the long-
term, biotechnologists may do more for the environment by developing novel
enzymes and other tools that allow the redesign of industrial processes, than by
developing bioremediation methods.
DO NOVEL BIOTECHNOLOGY PRODUCTS POSE NOVEL RISKS?
As of May 1996, government records indicated that in the United States there
had been about 3,500 field tests of genetically engineered plants, 50-100
field-tests of genetically engineered microorganisms, and two field-tests of
genetically engineered fish. These numbers continue to grow, involving an
ever greater diversity of genetically engineered organisms. I will examine
the environmental risks associated with genetically engineered products, as
these risks apply to species or taxa that only recently have been genetically
engineered.
Crop plants: Within the predominant group of engineered organisms —
plants — the range of species being field-tested until recently has been rela-
tively narrow. As of March 1993, about 85 percent of field-tests of genetically
engineered crops were of six species: corn, cotton, tomatoes, potatoes,
soybeans, and tobacco. However, the diversity of crops being genetically
engineered has increased substantially: transgenic varieties of more than 40
different crop plants have now been field-tested in the United States. These
include fruits and vegetables such as cranberries, papayas, raspberries, and
radicchio; ornamentals and turf plants such as chrysanthemums, gladioli,
petunias, and creeping bentgrass; and trees such as poplars, spruce, and
sweetgum. Moreover, the range of traits being introduced to crop plants is also
increasing. Along with insect, disease, and herbicide resistance — the traits
most commonly introduced to crops — a number of crops are now being
engineered to produce pharmaceuticals, polymers, and industrial enzymes,
and to alter oil, starch, and protein contents.
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The prominent ecological risk associated with crop plants is that they will
transfer, via pollination, their acquired genes to related wild or weedy plants,
or to other cultivated non-transgenic varieties of the same crop. How will these
gene transfer risks apply to the wider range of crop varieties now under
development?
The answer to this question is not straightforward. Gene transfer to wild
or weedy-related plants may pose both lower and higher risks. The primary
concern about such gene transfer is that the transferred genes may encode a
trait that confers a selective advantage. Populations of wild or weedy plants
that acquire the trait may increase to the extent that they become an ecological
or agricultural nuisance. Acquired traits for insect, disease, and herbicide
resistance — the traits that have long dominated genetic engineering of crop
plants — realistically could confer a selective advantage to a wild plant. How-
ever, it is difficult to envision many other traits now being engineered into
crops, such as production of pharmaceuticals, polymers, and industrial
enzymes, and altered oil, starch, and protein content, as conferring a selective
advantage to a wild plant. Therefore, transfer of such traits to wild or weedy
plants generally should pose low risks.
On the other hand, the wider diversity of plant species now being engineered
could increase the likelihood of gene transfer to wild or weedy plants. Concerns
about gene transfer by most of our major crops — the traditional focus of
genetic engineering efforts — are minimal in the United States. Most of these
crops originated in other areas of the world and do not have wild relatives in
the United States. Genetic engineers, however, now are focusing increasing
attention on plants such as forest trees and ornamentals that have wild popu-
lations in the United States. Many of these plants readily can transfer their
acquired traits to wild relatives, and thus have the potential to pose significant
gene transfer risks.
Gene transfer from transgenic varieties to cultivated non-transgenic varieties
of the same crop on average may pose higher risks than in the past. Gene trans-
fer to cultivated, non-transgenic varieties to date has not been a focus of great
concern, because most introduced genes are intended for use in food crops and
are intended to be safe for consumers. For example, consumers likely would
not be exposed to significant health hazards if a small percentage of a corn crop
acquired a herbicide-resistance gene from a transgenic corn growing nearby.
(One important exception to this generalization would be the transfer of
genes encoding substances that are safe for most consumers, but allergenic
for a minority of consumers, which would pose a serious risk for the allergic
minority.)
In contrast, genes encoding pharmaceuticals or industrial chemicals are not
intended to be used in foods, and expression products of such genes could pose
health hazards to consumers. Transfer of such genes from transgenic to non-
transgenic varieties could contaminate food derived from the non-transgenic
varieties, posing health risks to consumers.
Fish: Sharp declines in wild fish stocks and new technologies have created
strong economic incentives for aquaculture (fish farming). In the United States,
aquaculture production more than doubled between 1984 and 1993, and
aquaculture is now the fastest growing segment of agriculture. Worldwide,
aquaculture is growing by about 10 percent each year. Farmed shrimp, for
example, now are more than 30 percent of the world shrimp supply.
Interest in engineering aquatic organisms for aquaculture is growing rapidly,
potentially creating new environmental risks. One United States company, AF
Protein of Newton, Mass., has approached the United States Food and Drug
Administration for approval to commercialize Atlantic salmon engineered to
produce a growth hormone from chinook salmon. According to AF Protein,
their transgenic salmon fry grow 400-600 percent faster than their non-
engineered kin.
Such transgenic fish arguably pose some of the greatest risks of any type of
transgenic organisms. Aquaculture facilities are notoriously leaky. Data from
waters off Scotland’s Faroe Islands, for example, indicate that as many as 48
percent of the salmon caught by commercial fishermen have escaped from
salmon farms. In general, fish escaped from aquaculture facilities are reasonably
likely to survive and breed with natural fish populations, because most fish
have not been debilitated significantly by domestication. Therefore, transgenic
fish readily may transfer their engineered traits to wild fish populations, where
these traits might spread via natural selection. Having acquired an advan-
tageous trait, fish then could affect populations of other aquatic organisms —
for example, by competing for food. These sorts of ecological effects are of
concern particularly because considerable experience with introductions of
“exotic” fish from other geographic areas suggests that aquatic ecosystems are
highly vulnerable to ecological disruptions.
Invertebrates: Recently, a number of invertebrate species have been engi-
neered for the first time. In 1996, the USDA received the first applications for
field tests of transgenic mites and nematodes. In aquaculture, shrimp and
mollusks were first reported as transformed. Ecological risks posed by intro-
ductions of transgenic invertebrates have only begun to be examined. Those
risks especially merit scrutiny because many invertebrates are highly mobile
at certain life stages and have extremely high reproductive rates, and because
transgenic invertebrates readily may interbreed with wild conspecifics.
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NOVEL REGULATORY APPROACHES TO MANAGING ENVIRONMENTAL
IMPACTS OF AGRICULTURAL BIOTECHNOLOGY
Innovative new regulatory approaches may help our society better manage the
environmental risks and controversies associated with an expanding universe of
biotechnology products. One potentially helpful regulatory tool is conditional
registration of pesticides. For some products, conditional registrations may
strengthen environmental protection while providing significant advantages
for regulators and manufacturers.
In order to market a pesticide in the United States, the substance must be
registered by the U.S. Environmental Protection Agency (EPA) under the
Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). In general, a
company submits considerable data to the EPA concerning the human health
and environmental impacts of their product. Based on these data, the EPA
decides whether to register the pesticide. If the EPA chooses to conditionally
register a pesticide, the agency continues to require the submission of data over
a certain time period after the pesticide is commercialized.
FIFRA was originally amended to allow conditional registrations in order to
eliminate a double standard that arose as a result of increased data requirements
under the statute. Conditional registrations enabled the EPA to allow manu-
facturers to start selling a pesticide while working to fill data gaps, as long as
the EPA determined that the conditional registration would not increase sig-
nificantly the risk of any unreasonable adverse effect on the environment.
The EPA’s use of conditional registrations took an unprecedented turn
in March 1994, when the agency granted a landmark registration to two
agrochemical companies — Monsanto Company and Zeneca AG — for the
herbicide acetochlor. The EPA conditionally registered acetochlor on the basis
of arguments by the herbicide’s manufacturers that the availability of acetochlor
would greatly reduce overall herbicide use on midwestern corn crops. Amid
considerable controversy, the EPA weighed the manufacturer’s arguments for
environmental benefits against other evidence that acetochlor is carcinogenic
and may leach into ground water. Taking an unprecedented step, the EPA
registered acetochlor, but established a number of conditions for continuing the
registration beyond an initial five year period. Monsanto and Zeneca must
document promised decreases in herbicide use and must fund programs to
monitor ground water and surface water for acetochlor contamination. If the
companies do not meet these conditions, the EPA will cancel the pesticide’s
registration.
The EPA subsequently issued several conditional registrations involving
genetically engineered crops. In May 1995, the agency conditionally registered
bromoxynil for use on cotton that was genetically engineered to tolerate this
herbicide. This registration was highly controversial because bromoxynil is
absorbed through the skin and is a reproductive toxin, thus posing health risks
to farm workers. However, bromoxynil’s manufacturer argued that use of
bromoxynil-tolerant cotton would lead to a decrease in overall use of more
hazardous herbicides on cotton. Similar to acetochlor, the EPA conditioned
bromoxynil’s registration on the requirement that the manufacture substantiate
its claims of a net environmental benefit.
Later in 1995 and in 1996, the EPA conditioned registrations of corn and
cotton genetically engineered to express insecticidal Bt toxins from bacteria.
Preparations of naturally occurring Bt bacteria already are used as a safe
insecticide on relatively limited acreage by both conventional and organic
farmers. Many scientists are concerned that genetically engineered Bt crops
will be planted widely, leading insect pests rapidly to evolve resistance to Bt
toxins, and rendering Bt useless in both genetically engineered crops and as a
natural insecticide. The EPA conditionally registered Bt corn and Bt cotton to
require that the crops’ manufacturers establish programs to prevent or slow the
evolution of insect pests’ resistant to Bt.
Recent conditional registrations are distinct from previous conditional regis-
trations in the scope and kind of data they require. They are not appropriate
for all products, because they involve some extra time and effort on the part
of agency and company staff. However, they can be a “win-win” regulatory
solution in certain situations. Conditional registrations have at least four
compelling advantages:
1. Conditional registrations build into EPA’s regulatory program for
pesticides powerful new incentives for companies to evaluate
carefully and honestly the environmental implications of their
products. If a company cannot document within a specific time
period the performance it promises for a pesticide — e.g. that
Bt-resistance will not evolve — the company’s registration may
be canceled.
2. The fact that companies must document their claims, which other-
wise are easy to exaggerate, should give regulators considerable
new confidence in the information companies provide and should
boost shaky public confidence in regulatory decisions concerning
pesticides.
3. Manufacturers should gain from the EPA’s formal consideration of
a company ‘s environmental performance predictions that now are
not generally considered as part of the registration process.
4. Manufacturers gain orderly decisions allowing the commercial-
ization of controversial products that otherwise might be tied up
in lengthy regulatory debates.
In short, conditional registrations are not a panacea. They have the potential,
however, to enable the EPA to establish strong incentives for companies to
develop pesticides that provide net environmental benefits and to practice
environmental stewardship in the management of pesticide products.
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CONCLUSION
The expanding universe of biotechnology products will broaden the range of
environmental risks and controversies associated with biotechnology products.
However, the diversity of new products means that while some will become
the focus of new concern and debate, others may arouse little interest from
environmentalists. Innovative new regulatory approaches are one way in
which our society may manage better those products that spur environmental
controversies.
